Exhibit 32.1


--------------------------------------------------------------------------------
                         DIAPULSE CORPORATION OF AMERICA
                                   FORM 10-QSB
                 FOR THE QUARTER PERIOD ENDED SEPTEMBER 30, 2004

--------------------------------------------------------------------------------


                          I, Jesse Ross, certify that:

1.   I have reviewed this quarterly report on Form 10-QSB of Diapulse
     Corporation of America, Inc.;

2.   Based on my knowledge, this quarterly report does not contain any untrue
     statement of a material fact or omit to state a material fact necessary to
     make the statements made, in light of the circumstances under which such
     statements were made, not misleading with respect to the period covered by
     this quarterly report; and

3.   Based on my knowledge, the financial statements, and other financial
     information included in this quarterly report, fairly present in all
     material respects the financial condition, results of operation and cash
     flows of the registrant as of, and for, the periods presented in this
     quarterly report.

4.   I am responsible for establishing and maintaining disclosure controls and
     procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
     registrant and have

     a)   designed such disclosure controls and procedures to ensure that
          material information relating to the registrant, including its
          consolidated subsidiaries, is made known to us by others within those
          entities, particularly during the period in which this quarterly
          report is being prepared;

     b)   evaluated the effectiveness of the registrant's disclosure controls
          and procedures as of a date within 90 days prior to the filing date of
          this quarterly report (the "Evaluation Date"); and

5.   I have disclosed, based on my most recent evaluation, to the registrant's
     auditors and the audit committee of registrant's board of directors (or
     persons performing the equivalent function):

     a)   all significant deficiencies in the design or operation of internal
          controls which could adversely affect the registrant's ability to
          record, process, summarize and report financial data and have
          identified for the registrant's auditors any material weaknesses in
          internal controls; and


<PAGE>

--------------------------------------------------------------------------------
                         DIAPULSE CORPORATION OF AMERICA
                                   FORM 10-QSB
                 FOR THE QUARTER PERIOD ENDED SEPTEMBER 30, 2004

--------------------------------------------------------------------------------

     b)   any fraud, whether or not material, that involves management or other
          employees who have a significant role in the registrant's internal
          controls; and

6.   I have indicated in this quarterly report whether or not there were
     significant changes in internal controls or in other factors that could
     significantly affect internal controls subsequent to the date of our most
     recent evaluation, including any corrective actions with regard to
     significant deficiencies and material weaknesses.

                                        Date:   November 2, 2004

                                          By:   /s/ Jesse Ross
                                               -----------------------------
                                               Jesse Ross
                                               Chief Executive Officer and
                                               Principal Financial Officer